{
  "citations": [
    {
      "id": 7283333,
      "title": "Pharmacogenetics: from bench to byte--an update of guidelines.",
      "_sameAs": "https://www.ncbi.nlm.nih.gov/pubmed/21412232",
      "authors": [
        "Swen J J",
        "Nijenhuis M",
        "de Boer A",
        "Grandia L",
        "Maitland-van der Zee A H",
        "Mulder H",
        "Rongen G A P J M",
        "van Schaik R H N",
        "Schalekamp T",
        "Touw D J",
        "van der Weide J",
        "Wilffert B",
        "Deneer V H M",
        "Guchelaar H-J"
      ],
      "crossReferences": [
        {
          "id": 769250885,
          "resource": "PubMed",
          "resourceId": "21412232",
          "_url": "https://www.ncbi.nlm.nih.gov/pubmed/21412232",
          "version": 0
        },
        {
          "id": 1449247827,
          "resource": "DOI",
          "resourceId": "10.1038/clpt.2011.34",
          "_url": "http://dx.doi.org/10.1038%2Fclpt.2011.34",
          "version": 0
        }
      ],
      "hasKeyword": true,
      "journal": "Clinical pharmacology and therapeutics",
      "meshDiseases": [],
      "meshTerms": [
        "Animals",
        "Aryl Hydrocarbon Hydroxylases",
        "Cytochrome P-450 CYP2C9",
        "Drug Administration Schedule",
        "Drug-Related Side Effects and Adverse Reactions",
        "Humans",
        "Pharmaceutical Preparations",
        "Pharmacogenetics",
        "Practice Guidelines as Topic"
      ],
      "month": 5,
      "nonHuman": false,
      "objCls": "Literature",
      "page": "662-73",
      "pediatric": false,
      "pgkbPublication": false,
      "pubDate": "2011-05-01T00:00:00-07:00",
      "summary": "Currently, there are very few guidelines linking the results of pharmacogenetic tests to specific therapeutic recommendations. Therefore, the Royal Dutch Association for the Advancement of Pharmacy established the Pharmacogenetics Working Group with the objective of developing pharmacogenetics-based therapeutic (dose) recommendations. After systematic review of the literature, recommendations were developed for 53 drugs associated with genes coding for CYP2D6, CYP2C19, CYP2C9, thiopurine-S-methyltransferase (TPMT), dihydropyrimidine dehydrogenase (DPD), vitamin K epoxide reductase (VKORC1), uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1), HLA-B44, HLA-B*5701, CYP3A5, and factor V Leiden (FVL).",
      "terms": [],
      "version": 2,
      "volume": "89",
      "year": 2011
    }
  ],
  "guideline": {
    "objCls": "Guideline Annotation",
    "id": "PA166104934",
    "name": "Annotation of DPWG Guideline for azathioprine and TPMT",
    "alternateDrugAvailable": false,
    "cancerGenome": false,
    "crossReferences": [],
    "dosingInformation": false,
    "guidelineGenes": [
      {
        "id": 1451450160,
        "alleles": [
          {
            "id": 1451450161,
            "_label": "*1",
            "function": {
              "id": 1445558335,
              "parents": [],
              "resource": "Allele Function",
              "term": "Normal function",
              "termId": "haplotypeTags:1445558335",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165819268",
              "symbol": "TPMT*1",
              "name": "*1",
              "version": 16
            },
            "version": 0
          },
          {
            "id": 1451450162,
            "_label": "*2",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165819269",
              "symbol": "TPMT*2",
              "name": "*2",
              "version": 14
            },
            "version": 0
          },
          {
            "id": 1451450163,
            "_label": "*3A",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165819270",
              "symbol": "TPMT*3A",
              "name": "*3A",
              "version": 15
            },
            "version": 0
          },
          {
            "id": 1451450164,
            "_label": "*3B",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165819271",
              "symbol": "TPMT*3B",
              "name": "*3B",
              "version": 14
            },
            "version": 0
          },
          {
            "id": 1451450165,
            "_label": "*3C",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165819272",
              "symbol": "TPMT*3C",
              "name": "*3C",
              "version": 14
            },
            "version": 0
          },
          {
            "id": 1451701164,
            "_label": "*3D",
            "allele": "*3D",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "version": 0
          },
          {
            "id": 1451450166,
            "_label": "*4",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165819274",
              "symbol": "TPMT*4",
              "name": "*4",
              "version": 14
            },
            "version": 0
          },
          {
            "id": 1451450180,
            "_label": "*5",
            "allele": "*5",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "version": 0
          },
          {
            "id": 1451450181,
            "_label": "*6",
            "allele": "*6",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "version": 0
          },
          {
            "id": 1451450200,
            "_label": "*7",
            "allele": "*7",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "version": 0
          },
          {
            "id": 1451450201,
            "_label": "*8",
            "allele": "*8",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "version": 0
          },
          {
            "id": 1451450202,
            "_label": "*9",
            "allele": "*9",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "version": 0
          },
          {
            "id": 1451450203,
            "_label": "*10",
            "allele": "*10",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "version": 0
          },
          {
            "id": 1451450167,
            "_label": "*11",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165819281",
              "symbol": "TPMT*11",
              "name": "*11",
              "version": 14
            },
            "version": 0
          },
          {
            "id": 1451450204,
            "_label": "*12",
            "allele": "*12",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "version": 0
          },
          {
            "id": 1451450205,
            "_label": "*13",
            "allele": "*13",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "version": 0
          },
          {
            "id": 1451450168,
            "_label": "*14",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165819284",
              "symbol": "TPMT*14",
              "name": "*14",
              "version": 14
            },
            "version": 0
          },
          {
            "id": 1451450169,
            "_label": "*15",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165819285",
              "symbol": "TPMT*15",
              "name": "*15",
              "version": 14
            },
            "version": 0
          },
          {
            "id": 1451450206,
            "_label": "*16",
            "allele": "*16",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "version": 0
          },
          {
            "id": 1451450207,
            "_label": "*17",
            "allele": "*17",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "version": 0
          },
          {
            "id": 1451450208,
            "_label": "*18",
            "allele": "*18",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "version": 0
          }
        ],
        "gene": {
          "objCls": "Gene",
          "id": "PA356",
          "symbol": "TPMT",
          "name": "thiopurine S-methyltransferase",
          "alleleFile": "TPMT_allele_definition_table.xlsx",
          "altNames": {},
          "buildVersion": "GRCh38",
          "cbStart": "p22.3",
          "cbStop": "p22.3",
          "chr": {
            "objCls": "Chromosome",
            "id": "PA532",
            "name": "chr6",
            "version": 3
          },
          "chrStartPosB37": 18128542,
          "chrStartPosB38": 18128311,
          "chrStopPosB37": 18155400,
          "chrStopPosB38": 18155169,
          "cpicGene": true,
          "crossReferences": [
            {
              "id": 553237364,
              "resource": "Comparative Toxicogenomics Database",
              "resourceId": "7172",
              "_url": "http://ctdbase.org/detail.go?type=gene&acc=7172",
              "version": 0
            },
            {
              "id": 132272227,
              "resource": "Ensembl",
              "resourceId": "ENSG00000137364",
              "_url": "https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000137364",
              "version": 0
            },
            {
              "id": 83901,
              "resource": "GenAtlas",
              "resourceId": "TPMT",
              "_url": "http://genatlas.medecine.univ-paris5.fr/fiche.php?symbol=TPMT",
              "version": 1
            },
            {
              "id": 98829,
              "resource": "GeneCard",
              "resourceId": "TPMT",
              "_url": "https://www.genecards.org/cgi-bin/carddisp.pl?gene=TPMT",
              "version": 1
            },
            {
              "id": 608112626,
              "resource": "HGNC",
              "resourceId": "HGNC:12014",
              "_url": "https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC%3A12014",
              "version": 1
            },
            {
              "id": 608112636,
              "resource": "HumanCyc Gene",
              "resourceId": "HS06327",
              "_url": "http://biocyc.org/HUMAN/NEW-IMAGE?object=HS06327",
              "version": 0
            },
            {
              "id": 560935362,
              "resource": "ModBase",
              "resourceId": "O43213",
              "_url": "http://salilab.org/modbase/search?modelflag=longest&databaseID=O43213",
              "version": 0
            },
            {
              "id": 466439,
              "resource": "MutDB",
              "resourceId": "TPMT",
              "_url": "http://www.mutdb.org/genes/search?_method=POST&data%5BSearch%5D%5Bidentifier%5D=TPMT",
              "version": 1
            },
            {
              "id": 20259,
              "resource": "NCBI Gene",
              "resourceId": "7172",
              "_url": "https://www.ncbi.nlm.nih.gov/gene/7172",
              "version": 1
            },
            {
              "id": 2403,
              "resource": "OMIM",
              "resourceId": "187680",
              "_url": "https://omim.org/entry/187680",
              "version": 1
            },
            {
              "id": 560550106,
              "resource": "OMIM",
              "resourceId": "610460",
              "_url": "https://omim.org/entry/610460",
              "version": 0
            },
            {
              "id": 1451618680,
              "resource": "RefSeq DNA",
              "resourceId": "NG_012137.3",
              "_url": "https://www.ncbi.nlm.nih.gov/nuccore/NG_012137.3",
              "version": 0
            },
            {
              "id": 37533,
              "resource": "RefSeq Protein",
              "resourceId": "NP_000358",
              "_url": "https://www.ncbi.nlm.nih.gov/nuccore/NP_000358",
              "version": 1
            },
            {
              "id": 46608,
              "resource": "RefSeq RNA",
              "resourceId": "NM_000367",
              "_url": "https://www.ncbi.nlm.nih.gov/nuccore/NM_000367",
              "version": 1
            },
            {
              "id": 121925,
              "resource": "UCSC Genome Browser",
              "resourceId": "NM_000367",
              "_url": "https://genome.ucsc.edu/cgi-bin/hgTracks?Submit=Submit&position=NM_000367",
              "version": 1
            },
            {
              "id": 62331854,
              "name": "TPMT_HUMAN",
              "resource": "UniProtKB",
              "resourceId": "P51580",
              "_url": "https://www.uniprot.org/uniprot/P51580",
              "version": 1
            },
            {
              "id": 608112635,
              "name": "Q9BS45_HUMAN",
              "resource": "UniProtKB",
              "resourceId": "Q9BS45",
              "_url": "https://www.uniprot.org/uniprot/Q9BS45",
              "version": 1
            }
          ],
          "hasNonStandardHaplotypes": false,
          "hideHaplotypes": false,
          "pharmVarGene": false,
          "strand": "minus",
          "terms": [
            {"id":560499969,"_url":"http://amigo.geneontology.org/amigo/term/GO:0005625","resource":"Gene Ontology","term":"soluble fraction","termId":"GO:0005625"},
            {"id":560500078,"_url":"http://amigo.geneontology.org/amigo/term/GO:0005737","resource":"Gene Ontology","term":"cytoplasm","termId":"GO:0005737"},
            {"id":560500177,"_url":"http://amigo.geneontology.org/amigo/term/GO:0005829","resource":"Gene Ontology","term":"cytosol","termId":"GO:0005829"},
            {"id":560500558,"_url":"http://amigo.geneontology.org/amigo/term/GO:0006139","resource":"Gene Ontology","term":"nucleobase, nucleoside, nucleotide and nucleic acid metabolic process","termId":"GO:0006139"},
            {"id":560502520,"_url":"http://amigo.geneontology.org/amigo/term/GO:0008119","resource":"Gene Ontology","term":"thiopurine S-methyltransferase activity","termId":"GO:0008119"},
            {"id":560501456,"_url":"http://amigo.geneontology.org/amigo/term/GO:0008152","resource":"Gene Ontology","term":"metabolic process","termId":"GO:0008152"},
            {"id":560498395,"_url":"http://amigo.geneontology.org/amigo/term/GO:0008168","resource":"Gene Ontology","term":"methyltransferase activity","termId":"GO:0008168"},
            {"id":560505035,"_url":"http://amigo.geneontology.org/amigo/term/GO:0014070","resource":"Gene Ontology","term":"response to organic cyclic substance","termId":"GO:0014070"},
            {"id":560495039,"_url":"http://amigo.geneontology.org/amigo/term/GO:0016740","resource":"Gene Ontology","term":"transferase activity","termId":"GO:0016740"},
            {"id":560513429,"_url":"http://amigo.geneontology.org/amigo/term/GO:0033574","resource":"Gene Ontology","term":"response to testosterone stimulus","termId":"GO:0033574"},
            {"id":560508927,"_url":"http://amigo.geneontology.org/amigo/term/GO:0046498","resource":"Gene Ontology","term":"S-adenosylhomocysteine metabolic process","termId":"GO:0046498"},
            {"id":560501101,"_url":"http://amigo.geneontology.org/amigo/term/GO:0046500","resource":"Gene Ontology","term":"S-adenosylmethionine metabolic process","termId":"GO:0046500"}
          ],
          "version": 7544
        },
        "version": 1
      }
    ],
    "hasTestingInfo": true,
    "history": [
      {
        "id": 1183704447,
        "date": "2011-08-10T00:00:00-07:00",
        "type": "Create",
        "version": 0
      },
      {
        "id": 1450414858,
        "date": "2019-05-22T10:52:57.667-07:00",
        "description": "Annotation current with November 2018 DPWG Guideline release",
        "type": "Update",
        "version": 0
      },
      {
        "id": 1450820691,
        "date": "2019-10-03T21:26:59.435-07:00",
        "description": "Changes based on August 2019 guidelines",
        "type": "Update",
        "version": 0
      },
      {
        "id": 1450956223,
        "date": "2020-01-31T13:18:57.518-08:00",
        "description": "Updated link to 2011 DPWG methods",
        "type": "Update",
        "version": 0
      },
      {
        "id": 1450962680,
        "date": "2020-02-10T10:04:01.972-08:00",
        "description": "Fixed links to 2019 guideline pdfs. 2018 link already went to attachment.",
        "type": "Update",
        "version": 0
      },
      {
        "id": 1451153260,
        "date": "2020-06-01T14:44:37.803-07:00",
        "description": "Changes based on May 2020 guidelines",
        "type": "Update",
        "version": 0
      },
      {
        "id": 1451450504,
        "date": "2021-05-26T00:00:00-07:00",
        "description": "Added extended dosing pull down menu.",
        "type": "Update",
        "version": 0
      },
      {
        "id": 1451450604,
        "date": "2021-05-26T11:21:25.196-07:00",
        "description": "Tagged haplotypes.",
        "type": "Update",
        "version": 0
      },
      {
        "id": 1451701165,
        "date": "2022-03-02T00:00:00-08:00",
        "description": "Added *3D allele to extended dosing guideline",
        "type": "Update",
        "version": 0
      },
      {
        "id": 1451704187,
        "date": "2022-03-03T16:33:24.105-08:00",
        "description": "Annotation current with May 2021 DPWG Guideline release",
        "type": "Note",
        "version": 0
      },
      {
        "id": 1451706220,
        "date": "2022-03-07T15:31:10.535-08:00",
        "description": "Added information about preemptive genotyping",
        "type": "Update",
        "version": 0
      },
      {
        "id": 1451732827,
        "date": "2022-03-28T09:57:37.791-07:00",
        "description": "Annotation current with February 2022 DPWG guideline release",
        "type": "Note",
        "version": 0
      },
      {
        "id": 1451733292,
        "date": "2022-03-28T14:33:43.029-07:00",
        "description": "Updated link to testing guidance page",
        "type": "Update",
        "version": 0
      },
      {
        "id": 1451741466,
        "date": "2022-04-05T11:10:33.367-07:00",
        "description": "Added testing guidance tag",
        "type": "Update",
        "version": 0
      },
      {
        "id": 1451884093,
        "date": "2022-09-16T09:43:41.615-07:00",
        "description": "Fixed link to gene information document and added explanatory note",
        "type": "Update",
        "version": 0
      }
    ],
    "literature": [
      {"id":7283333,"title":"Pharmacogenetics: from bench to byte--an update of guidelines.","_sameAs":"https://www.ncbi.nlm.nih.gov/pubmed/21412232","crossReferences":[{"id":769250885,"resource":"PubMed","resourceId":"21412232","_url":"https://www.ncbi.nlm.nih.gov/pubmed/21412232"},{"id":1449247827,"resource":"DOI","resourceId":"10.1038/clpt.2011.34","_url":"http://dx.doi.org/10.1038%2Fclpt.2011.34"}],"objCls":"Literature","terms":[]},
      {"id":15103288,"title":"Dutch Pharmacogenetics Working Group Guidelines August 2019","_sameAs":"https://api.pharmgkb.org/v1/preview/download/file/attachment/DPWG_August_2019.pdf","crossReferences":[{"id":1450815695,"resource":"URL","resourceId":"https://api.pharmgkb.org/v1/preview/download/file/attachment/DPWG_August_2019.pdf","_url":"https://api.pharmgkb.org/v1/preview/download/file/attachment/DPWG_August_2019.pdf"}],"objCls":"Literature","terms":[]},
      {"id":15111722,"title":"Dutch Pharmacogenetics Working Group Guidelines May 2020","_sameAs":"https://www.knmp.nl/downloads/pharmacogenetic-recommendations-may-2020.pdf","crossReferences":[{"id":1451152900,"resource":"URL","resourceId":"https://www.knmp.nl/downloads/pharmacogenetic-recommendations-may-2020.pdf","_url":"https://www.knmp.nl/downloads/pharmacogenetic-recommendations-may-2020.pdf"}],"objCls":"Literature","terms":[]},
      {"id":15102465,"title":"Dutch Pharmacogenetics Working Group Guidelines November 2018","_sameAs":"https://api.pharmgkb.org/v1/preview/download/file/attachment/DPWG_November_2018.pdf","crossReferences":[{"id":1450415575,"resource":"URL","resourceId":"https://api.pharmgkb.org/v1/preview/download/file/attachment/DPWG_November_2018.pdf","_url":"https://api.pharmgkb.org/v1/preview/download/file/attachment/DPWG_November_2018.pdf"}],"objCls":"Literature","terms":[]}
    ],
    "pediatric": false,
    "recommendation": true,
    "relatedAlleles": [
      {
        "objCls": "Haplotype",
        "id": "PA165819268",
        "symbol": "TPMT*1",
        "name": "*1",
        "version": 16
      },
      {
        "objCls": "Haplotype",
        "id": "PA165819280",
        "symbol": "TPMT*10",
        "name": "*10",
        "version": 14
      },
      {
        "objCls": "Haplotype",
        "id": "PA165819281",
        "symbol": "TPMT*11",
        "name": "*11",
        "version": 14
      },
      {
        "objCls": "Haplotype",
        "id": "PA165819282",
        "symbol": "TPMT*12",
        "name": "*12",
        "version": 14
      },
      {
        "objCls": "Haplotype",
        "id": "PA165819283",
        "symbol": "TPMT*13",
        "name": "*13",
        "version": 14
      },
      {
        "objCls": "Haplotype",
        "id": "PA165819284",
        "symbol": "TPMT*14",
        "name": "*14",
        "version": 14
      },
      {
        "objCls": "Haplotype",
        "id": "PA165819285",
        "symbol": "TPMT*15",
        "name": "*15",
        "version": 14
      },
      {
        "objCls": "Haplotype",
        "id": "PA165819286",
        "symbol": "TPMT*16",
        "name": "*16",
        "version": 14
      },
      {
        "objCls": "Haplotype",
        "id": "PA165819287",
        "symbol": "TPMT*17",
        "name": "*17",
        "version": 14
      },
      {
        "objCls": "Haplotype",
        "id": "PA165819288",
        "symbol": "TPMT*18",
        "name": "*18",
        "version": 14
      },
      {
        "objCls": "Haplotype",
        "id": "PA165819269",
        "symbol": "TPMT*2",
        "name": "*2",
        "version": 14
      },
      {
        "objCls": "Haplotype",
        "id": "PA165819270",
        "symbol": "TPMT*3A",
        "name": "*3A",
        "version": 15
      },
      {
        "objCls": "Haplotype",
        "id": "PA165819271",
        "symbol": "TPMT*3B",
        "name": "*3B",
        "version": 14
      },
      {
        "objCls": "Haplotype",
        "id": "PA165819272",
        "symbol": "TPMT*3C",
        "name": "*3C",
        "version": 14
      },
      {
        "objCls": "Haplotype",
        "id": "PA165819274",
        "symbol": "TPMT*4",
        "name": "*4",
        "version": 14
      },
      {
        "objCls": "Haplotype",
        "id": "PA165819275",
        "symbol": "TPMT*5",
        "name": "*5",
        "version": 14
      },
      {
        "objCls": "Haplotype",
        "id": "PA165819276",
        "symbol": "TPMT*6",
        "name": "*6",
        "version": 14
      },
      {
        "objCls": "Haplotype",
        "id": "PA165819277",
        "symbol": "TPMT*7",
        "name": "*7",
        "version": 14
      },
      {
        "objCls": "Haplotype",
        "id": "PA165819278",
        "symbol": "TPMT*8",
        "name": "*8",
        "version": 14
      },
      {
        "objCls": "Haplotype",
        "id": "PA165819279",
        "symbol": "TPMT*9",
        "name": "*9",
        "version": 14
      }
    ],
    "relatedChemicals": [
      {
        "objCls": "Chemical",
        "id": "PA448515",
        "name": "azathioprine",
        "version": 24
      }
    ],
    "relatedGenes": [
      {
        "objCls": "Gene",
        "id": "PA356",
        "symbol": "TPMT",
        "name": "thiopurine S-methyltransferase",
        "version": 7544
      }
    ],
    "source": "DPWG",
    "summaryMarkdown": {
      "id": 1447981850,
      "html": "<p>Select an alternative drug or reduce the initial dose of azathioprine for patients that are TPMT poor metabolizers and reduce initial dose for patients that are TPMT intermediate metabolizers.</p>\n",
      "version": 1
    },
    "terms": [],
    "textMarkdown": {
      "id": 1447981849,
      "html": "<h3 id=\"may-2020-update\">May 2020 Update</h3>\n<p><em><strong>IMPORTANT: As of March 2022, gene information documents from the DPWG are no longer publicly available from the KNMP website. PharmGKB is currently providing PDF versions of these documents to users. These files were downloaded in February 2022. As such, we cannot guarantee that these documents match the mappings DPWG may use internally as there have been no publicly accessible updates since February 2022.</strong></em></p>\n<p>The Royal Dutch Pharmacists Association - Pharmacogenetics Working Group has evaluated therapeutic dose recommendations for azathioprine based on TPMT genotype.  They recommend reducing the initial dose for patients that are intermediate metabolizers and selecting an alternative drug or reducing the initial dose for patients that are poor metabolizers. They removed the sentence &quot;The frequency of monitoring should be increased.&quot; from the previous recommendation.</p>\n<p><em>Wording in table taken from the <a download=\"DPWG_May_2020.pdf\" href=\"https://api.pharmgkb.org/v1/download/file/attachment/DPWG_May_2020.pdf\">Dutch guidelines May 2020 update</a>.</em></p>\n<table class=\"table\">\n<thead>\n<tr>\n<th>Allele/Genotype/Phenotype</th>\n<th>Drug</th>\n<th>Description</th>\n<th>Recommendation</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>TPMT IM</td>\n<td>azathioprine</td>\n<td>Grade ≥ 2 leukopaenia occurs in 23% of these patients with normal therapy for immunosuppression. The genetic variation increases the quantity of the active metabolites of azathioprine and mercaptopurine.</td>\n<td>-IMMUNOSUPPRESSION<br/>Start with 50% of the standard dose<br/>Adjustment of the initial dose should be guided by toxicity (monitoring of blood counts) and effectiveness.<br/>Dose adjustment is not required for doses lower than 1.5 mg/kg per day for azathioprine or 0.75 mg/kg per day for mercaptopurine.<br/>Note: more stringent dose reductions are necessary if the patient is also NUDT15 IM or NUDT15 PM.</td>\n</tr>\n<tr>\n<td>TPMT PM</td>\n<td>azathioprine</td>\n<td>Grade ≥ 2 leukopaenia and intolerance occurred in 98% of these patients with standard therapy. The gene variation increases the quantities of the active metabolites of azathioprine and mercaptopurine.</td>\n<td>Choose an alternative or start with 10% of the standard dose.<br/>Any adjustment of the initial dose should be guided by toxicity (monitoring of blood counts) and effectiveness.<br/>If the dose is decreased: advise patients to seek medical attention when symptoms of myelosuppression (such as severe sore throat in combination with fever, regular nosebleeds and tendency to bruising) occur.</td>\n</tr>\n</tbody>\n</table>\n<h4 id=\"preemptive-genotyping\">Preemptive genotyping</h4>\n<p>Excerpts from the <a rel=\"noopener noreferrer\" href=\"https://www.g-standaard.nl/risicoanalyse/B0001905.PDF\" target=\"_blank\">DPWG risk analysis document</a> for azathioprine and TPMT:</p>\n<blockquote class=\"blockquote\">\n<p>The Dutch Pharmacogenetics Working Group considers genotyping before starting azathioprine or 6-mercaptopurine to be essential for drug safety. Genotyping must be performed before drug therapy has been initiated to guide drug and dose selection.</p>\n</blockquote>\n<p><a href=\"/page/testingGuidance\">Read more about how DPWG assigns their recommendations for preemptive genotyping.</a></p>\n<p><a rel=\"noopener noreferrer\" href=\"https://www.g-standaard.nl/risicoanalyse/B0001905.PDF\" target=\"_blank\">Read for more information about this recommendation</a>. <a download=\"TPMT.pdf\" href=\"https://api.pharmgkb.org/v1/download/file/attachment/TPMT.pdf\">Read about gene information from DPWG</a></p>\n<h3 id=\"august-2019-update\">August 2019 Update</h3>\n<p>The Royal Dutch Pharmacists Association - Pharmacogenetics Working Group has evaluated therapeutic dose recommendations for azathioprine based on TPMT genotype.  They recommend reducing the initial dose for patients that are intermediate metabolizers and selecting an alternative drug or reducing the initial dose for patients that are poor metabolizers.</p>\n<p><em>Wording in table taken from the <a download=\"DPWG_August_2019.pdf\" href=\"https://api.pharmgkb.org/v1/download/file/attachment/DPWG_August_2019.pdf\">Dutch guidelines August 2019 update</a>.</em></p>\n<table class=\"table\">\n<thead>\n<tr>\n<th>Allele/Genotype/Phenotype</th>\n<th>Drug</th>\n<th>Description</th>\n<th>Recommendation</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>TPMT IM</td>\n<td>azathioprine</td>\n<td>The genetic variation reduces the conversion of azathioprine and mercaptopurine to mainly inactive metabolites. This increases the risk of serious, life-threatening adverse events such as myelosuppression.</td>\n<td>-IMMUNOSUPPRESSION<br/>Start with 50% of the standard dose<br/>Adjustment of the initial dose should be guided by toxicity (monitoring of blood counts) and effectiveness.<br/>The frequency of monitoring should be increased.<br/>Dose adjustment is not required for doses lower than 1.5 mg/kg per day for azathioprine or 0.75 mg/kg per day for mercaptopurine.<br/>Note: more stringent dose reductions are necessary if the patient is also NUDT15 IM.</td>\n</tr>\n<tr>\n<td>TPMT PM</td>\n<td>azathioprine</td>\n<td>The genetic variation reduces the conversion of azathioprine and mercaptopurine to mainly inactive metabolites. This increases the risk of serious, life-threatening adverse events such as myelosuppression.</td>\n<td>1. Choose an alternative or start with 10% of the standard dose.<br/>Any adjustment of the initial dose should be guided by toxicity (monitoring of blood counts) and effectiveness. The frequency of monitoring should be increased.<br/>2. If the dose is decreased: advise patients to seek medical attention when symptoms of myelosuppression (such as severe sore throat in combination with fever, regular nosebleeds and tendency to bruising) occur</td>\n</tr>\n</tbody>\n</table>\n<p><a rel=\"noopener noreferrer\" href=\"https://www.g-standaard.nl/risicoanalyse/B0001905.PDF\" target=\"_blank\">Read for more information about this recommendation</a>, <a rel=\"noopener noreferrer\" href=\"https://www.knmp.nl/producten/gebruiksrecht-g-standaard/medicatiebewaking-g-standaard/background-information-pharmacogenetics\" target=\"_blank\">Read about gene information from DPWG</a></p>\n<h3 id=\"november-2018-update\">November 2018 Update</h3>\n<p>The Royal Dutch Pharmacists Association - Pharmacogenetics Working Group has evaluated therapeutic dose recommendations for azathioprine based on TPMT genotype.  They recommend reducing the initial dose for patients that are intermediate metabolizers and selecting an alternative drug or reducing the initial dose for patients that are poor metabolizers.</p>\n<p><em>Wording in table taken from the <a download=\"DPWG_November_2018.pdf\" href=\"https://api.pharmgkb.org/v1/download/file/attachment/DPWG_November_2018.pdf\">Dutch guidelines November 2018 update</a>.</em></p>\n<table class=\"table\">\n<thead>\n<tr>\n<th>Allele/Genotype/Phenotype</th>\n<th>Drug</th>\n<th>Description</th>\n<th>Recommendation</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>TPMT IM</td>\n<td>azathioprine</td>\n<td>The genetic variation reduces the conversion of azathioprine and mercaptopurine to mainly inactive metabolites. This increases the risk of serious, life-threatening adverse events such as myelosuppression.</td>\n<td>Start with 50% of the standard dose. Adjustment of the initial dose should be guided by toxicity (monitoring of blood counts) and effectiveness. The frequency of monitoring should be increased. Dose adjustment is not required for doses lower than 1.5 mg/kg per day for azathioprine or 0.75 mg/kg per day for mercaptopurine.</td>\n</tr>\n<tr>\n<td>TPMT PM</td>\n<td>azathioprine</td>\n<td>The genetic variation reduces the conversion of azathioprine and mercaptopurine to mainly inactive metabolites. This increases the risk of serious, life-threatening adverse events such as myelosuppression.</td>\n<td>1. Choose an alternative or start with 10% of the standard dose.Any adjustment of the initial dose should be guided by toxicity (monitoring of blood counts) and effectiveness. The frequency of monitoring should be increased. 2. If the dose is decreased: advise patients to seek medical attention when symptoms of myelosuppression (such as severe sore throat in combination with fever, regular nosebleeds and tendency to bruising) occur.</td>\n</tr>\n</tbody>\n</table>\n<p><a rel=\"noopener noreferrer\" href=\"https://www.g-standaard.nl/risicoanalyse/B0001906.PDF\" target=\"_blank\">Read for more information about this recommendation</a>, <a rel=\"noopener noreferrer\" href=\"https://www.knmp.nl/producten/gebruiksrecht-g-standaard/medicatiebewaking-g-standaard/background-information-pharmacogenetics\" target=\"_blank\">Read about gene information from DPWG</a></p>\n<h3 id=\"2011-guideline\">2011 Guideline</h3>\n<p>The Royal Dutch Pharmacists Association - Pharmacogenetics Working Group has evaluated therapeutic dose recommendations for azathioprine based on TPMT genotype [Article:<a href=\"/pmid/21412232\">21412232</a>].  They recommend selecting an alternative drug or reducing the initial dose for patients carrying inactive alleles.</p>\n<table class=\"table\">\n<thead>\n<tr>\n<th>Phenotype (Genotype)</th>\n<th>Therapeutic Dose Recommendation</th>\n<th>Level of Evidence</th>\n<th>Clinical Relevance</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>IM (one inactive allele: *2, *3, *4-*18)</td>\n<td>Select alternative drug or reduce dose by 50%. Increase dose in response of hematologic monitoring and efficacy.</td>\n<td>Published controlled studies of good quality* relating to phenotyped and/or genotyped patients or healthy volunteers, and having relevant pharmacokinetic or clinical endpoints.</td>\n<td>Clinical effect (S): Failure of lifesaving therapy e.g. anticipated myelosuppression; prevention of breast cancer relapse; arrhythmia; neutropenia &lt; 0.5x10<sup>9</sup>/l; leucopenia &lt; 1.0x10<sup>9</sup>/l; thrombocytopenia &lt; 25x10<sup>9</sup>/l; life-threatening complications from diarrhea.</td>\n</tr>\n<tr>\n<td>PM (two inactive alleles: *2, *3, *4-*18)</td>\n<td>Select alternative drug or reduce dose by 90%. Increase dose in response of hematologic monitoring and efficacy.</td>\n<td>Published controlled studies of good quality* relating to phenotyped and/or genotyped patients or healthy volunteers, and having relevant pharmacokinetic or clinical endpoints.</td>\n<td>Clinical effect (S): death; arrhythmia; unanticipated myelosuppression.</td>\n</tr>\n</tbody>\n</table>\n<ul>\n<li>*See <a href=\"http://www.pharmgkb.org/page/dpwg\">Methods </a> or [Article:<a href=\"/pmid/18253145\">18253145</a>] for definition of &quot;good quality.&quot;</li>\n<li>S: statistically significant difference.</li>\n</ul>\n",
      "version": 16
    },
    "userId": "jmbarbarino",
    "version": 31
  }
}